Richard Treisman
British scientist
Richard Treisman
| Birth date | Birth date -1st March 1966 |
|---|---|
| Nationality | British |
| Known for | Serum response factor |
| Awards | EMBO Gold Medal, Fellow of the Royal Society |
Richard Treisman (born 7 December 1954) is a British molecular biologist known for his research on the Serum response factor (SRF) and its role in cell signaling and gene expression. He is a senior group leader at the Francis Crick Institute in London.
Early life and education
Richard Treisman was born on 7 December 1954. He completed his undergraduate studies at the University of Cambridge, where he developed an interest in molecular biology. He pursued his doctoral studies under the supervision of Richard J. Roberts, a Nobel laureate, focusing on the mechanisms of gene regulation.
Career and research
After completing his PhD, Treisman conducted postdoctoral research at the Imperial Cancer Research Fund (now part of Cancer Research UK). He later established his own research group at the Laboratory of Molecular Biology in Cambridge.
Treisman's research has significantly contributed to the understanding of the Serum response factor (SRF), a transcription factor that binds to the serum response element (SRE) in the promoter region of target genes. His work has elucidated the role of SRF in cell growth, differentiation, and apoptosis.
In 2000, Treisman was appointed as a group leader at the Francis Crick Institute, where he continues to investigate the molecular mechanisms underlying cell signaling and gene expression.
Awards and honors
Richard Treisman has received numerous awards for his contributions to molecular biology, including the EMBO Gold Medal in 1995. He was elected a Fellow of the Royal Society (FRS) in 2001, recognizing his outstanding achievements in scientific research.
Personal life
Richard Treisman is married and has two children. He is known for his dedication to mentoring young scientists and fostering a collaborative research environment.
See also
References
External links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
